Insider Trading activities of Elite Pharmaceuticals Inc /de/ insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Elite Pharmaceuticals Inc /de/ since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Elite Pharmaceuticals Inc /de/ since year 2005. Table 2 shows the detailed insider transactions of Elite Pharmaceuticals Inc /de/ since 2005. The reporting company's ticker symbol is ELTP. The reporting company's CIK number is 1053369.
The total value of stock buying since 2005 is $696,967.
The total value of stock sales since 2005 is $14,036,927.
The total value of stock option exercises since 2005 is $1,910,880.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Elite Pharmaceuticals Inc /de/ (ELTP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2016-08 0 $0 0 $0 142,857,143 $0
2016-03 0 $0 570,520 $196,054 0 $0
2016-02 0 $0 794,878 $261,035 0 $0
2016-01 0 $0 115,000 $40,250 0 $0
2015-11 0 $0 150,000 $45,275 0 $0
2015-04 0 $0 85,530 $20,185 0 $0
2014-09 700,000 $216,131 0 $0 0 $0
2014-05 0 $0 329,437 $125,844 0 $0
2014-04 0 $0 147,664 $60,542 0 $0
2014-03 0 $0 8,445,640 $6,288,147 180,000 $10,800
2014-01 0 $0 3,222,287 $589,676 0 $0
2013-12 0 $0 1,400,000 $176,100 0 $0
2013-11 0 $0 10,258,368 $1,211,874 0 $0
2013-10 0 $0 2,346,120 $289,784 0 $0
2013-01 0 $0 15,603,240 $1,543,468 30,160,000 $1,900,080
2012-12 0 $0 4,222,692 $382,862 0 $0
2012-04 0 $0 3,200 $454 0 $0
2012-03 0 $0 16,975,000 $1,603,515 0 $0
2012-01 0 $0 407,949 $48,953 0 $0
2011-05 0 $0 1,735,000 $241,190 0 $0
2011-04 0 $0 697,894 $70,072 0 $0
2011-03 0 $0 36,000 $3,024 0 $0
2011-02 3,345,973 $133,834 327,398 $19,643 0 $0
2011-01 0 $0 510,794 $34,044 0 $0
2010-12 0 $0 223,100 $10,037 0 $0
2010-11 0 $0 245,284 $13,103 0 $0
2010-10 0 $0 52,223 $3,133 0 $0
2010-09 0 $0 236,000 $13,972 0 $0
2010-07 500,000 $34,500 0 $0 0 $0
2010-05 0 $0 193,580 $16,904 0 $0
2010-04 0 $0 196,019 $15,765 0 $0
2010-01 0 $0 597,500 $65,929 0 $0
2009-12 0 $0 1,502,500 $192,793 0 $0
2009-11 0 $0 877,500 $94,048 0 $0
2009-10 0 $0 1,122,500 $112,800 0 $0
2009-07 0 $0 699,870 $48,020 0 $0
2009-04 0 $0 788,152 $114,772 0 $0
2008-09 10,000 $900 0 $0 0 $0
2008-07 85,000 $30,240 0 $0 0 $0
2008-04 15,000 $12,000 0 $0 0 $0
2008-03 10,000 $9,295 0 $0 0 $0
2008-02 40,000 $33,350 0 $0 0 $0
2008-01 52,000 $55,300 0 $0 0 $0
2007-12 5,000 $10,320 0 $0 0 $0
2007-11 22,500 $47,240 0 $0 0 $0
2006-07 7,000 $16,541 0 $0 0 $0
2005-07 12,000 $36,816 0 $0 0 $0
2005-06 20,000 $60,500 0 $0 0 $0
2005-03 0 $0 20,000 $83,660 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Elite Pharmaceuticals Inc /de/ insiders (ELTP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2016-08-17 Hakim Nasrat A (CEO & President) Option Ex 142,857,143 .00 0
2016-03-18 Treppel Jerry (Other) Sale 258,090 .34 88,266
2016-03-17 Treppel Jerry (Other) Sale 312,430 .34 107,788
2016-02-17 Treppel Jerry (Other) Sale 50,000 .31 15,600
2016-02-05 Treppel Jerry (Other) Sale 24,400 .33 8,052
2016-02-04 Treppel Jerry (Other) Sale 349,660 .32 111,891
2016-02-03 Treppel Jerry (Other) Sale 45,518 .33 15,020
2016-02-02 Treppel Jerry (Other) Sale 13,000 .33 4,290
2016-02-01 Treppel Jerry (Other) Sale 312,300 .34 106,182
2016-01-29 Treppel Jerry (Other) Sale 115,000 .35 40,250
2015-11-18 Treppel Jerry (Chairman of Board) Sale 25,000 .30 7,625
2015-11-17 Treppel Jerry (Chairman of Board) Sale 25,000 .30 7,500
2015-11-16 Treppel Jerry (Chairman of Board) Sale 50,000 .30 15,150
2015-11-13 Treppel Jerry (Chairman of Board) Sale 50,000 .30 15,000
2015-04-27 Plassche Douglas (Executive VP of Operations) Sale 85,530 .24 20,185
2014-09-26 Hakim Nasrat A (CEO & President) Buy 265,500 .31 82,305
2014-09-25 Hakim Nasrat A (CEO & President) Buy 434,500 .31 133,826
2014-05-09 Narine Jeenarine (Director) Sale 329,437 .38 125,844
2014-04-02 Narine Jeenarine (Director) Sale 147,664 .41 60,542
2014-03-27 Narine Jeenarine (Director) Sale 190,172 .43 81,203
2014-03-12 Treppel Jerry (Chairman of the Board) Option Ex 180,000 .06 10,800
2014-03-11 Epic Investments, Llc (10% Owner) Sale 239,367 .60 144,098
2014-03-11 Nigalaye Ashok G (Chief Scientific Officer) Sale 239,367 .60 144,098
2014-03-11 Narine Jeenarine (Director) Sale 239,367 .60 144,098
2014-03-11 Epic Pharma Llc (10% Owner) Sale 239,367 .60 144,098
2014-03-07 Epic Investments, Llc (10% Owner) Sale 1,051,450 .68 714,986
2014-03-07 Nigalaye Ashok G (Chief Scientific Officer) Sale 1,051,450 .68 714,986
2014-03-07 Narine Jeenarine (Director) Sale 1,051,450 .68 714,986
2014-03-07 Epic Pharma Llc (10% Owner) Sale 1,051,450 .68 714,986
2014-03-06 Epic Investments, Llc (10% Owner) Sale 773,050 .90 692,652
2014-03-06 Nigalaye Ashok G (Chief Scientific Officer) Sale 773,050 .90 692,652
2014-03-06 Narine Jeenarine (Director) Sale 773,050 .90 692,652
2014-03-06 Epic Pharma Llc (10% Owner) Sale 773,050 .90 692,652
2014-01-13 Epic Investments, Llc (10% Owner) Sale 805,538 .18 147,413
2014-01-13 Nigalaye Ashok G (Chief Scientific Officer) Sale 805,583 .18 147,421
2014-01-13 Narine Jeenarine (Director) Sale 805,583 .18 147,421
2014-01-13 Epic Pharma Llc (10% Owner) Sale 805,583 .18 147,421
2013-12-05 Epic Investments, Llc (10% Owner) Sale 275,000 .13 34,650
2013-12-05 Nigalaye Ashok G (Chief Scientific Officer) Sale 275,000 .13 34,650
2013-12-05 Narine Jeenarine (Director) Sale 275,000 .13 34,650
2013-12-05 Epic Pharma Llc (10% Owner) Sale 275,000 .13 34,650
2013-12-02 Epic Investments, Llc (10% Owner) Sale 100,000 .12 12,500
2013-12-02 Nigalaye Ashok G (Chief Scientific Officer) Sale 100,000 .12 12,500
2013-12-02 Epic Pharma Llc (10% Owner) Sale 100,000 .12 12,500
2013-11-27 Epic Investments, Llc (10% Owner) Sale 25,000 .12 3,025
2013-11-27 Nigalaye Ashok G (Chief Scientific Officer) Sale 25,000 .12 3,025
2013-11-27 Narine Jeenarine (Director) Sale 25,000 .12 3,025
2013-11-27 Epic Pharma Llc (10% Owner) Sale 25,000 .12 3,025
2013-11-26 Epic Investments, Llc (10% Owner) Sale 380,626 .12 45,984
2013-11-26 Nigalaye Ashok G (Chief Scientific Officer) Sale 380,626 .12 45,984
2013-11-26 Narine Jeenarine (Director) Sale 380,626 .12 45,984
2013-11-26 Epic Pharma Llc (10% Owner) Sale 380,626 .12 45,984
2013-11-19 Epic Investments, Llc (10% Owner) Sale 21,000 .12 2,457
2013-11-19 Nigalaye Ashok G (Chief Scientific Officer) Sale 21,000 .12 2,457
2013-11-19 Narine Jeenarine (Director) Sale 21,000 .12 2,499
2013-11-19 Epic Pharma Llc (10% Owner) Sale 21,000 .12 2,457
2013-11-18 Epic Investments, Llc (10% Owner) Sale 1,170,000 .12 138,060
2013-11-18 Nigalaye Ashok G (Chief Scientific Officer) Sale 1,170,000 .12 138,060
2013-11-18 Narine Jeenarine (Director) Sale 1,170,000 .12 138,060
2013-11-18 Epic Pharma Llc (10% Owner) Sale 1,170,000 .12 138,060
2013-11-15 Epic Investments, Llc (10% Owner) Sale 318,050 .12 37,211
2013-11-15 Nigalaye Ashok G (Chief Scientific Officer) Sale 318,050 .12 37,211
2013-11-15 Narine Jeenarine (Director) Sale 318,050 .12 37,211
2013-11-15 Epic Pharma Llc (10% Owner) Sale 318,050 .12 37,211
2013-11-14 Epic Investments, Llc (10% Owner) Sale 465,090 .12 53,485
2013-11-14 Nigalaye Ashok G (Chief Scientific Officer) Sale 465,090 .12 53,485
2013-11-14 Narine Jeenarine (Director) Sale 465,090 .12 53,485
2013-11-14 Epic Pharma Llc (10% Owner) Sale 465,090 .12 53,485
2013-11-11 Epic Investments, Llc (10% Owner) Sale 39,000 .12 4,797
2013-11-11 Nigalaye Ashok G (Chief Scientific Officer) Sale 39,000 .12 4,797
2013-11-11 Narine Jeenarine (Director) Sale 39,000 .12 4,797
2013-11-11 Epic Pharma Llc (10% Owner) Sale 39,000 .12 4,797
2013-11-06 Epic Investments, Llc (10% Owner) Sale 122,200 .12 15,152
2013-11-06 Nigalaye Ashok G (Chief Scientific Officer) Sale 122,200 .12 15,152
2013-11-06 Narine Jeenarine (Director) Sale 122,200 .12 15,152
2013-11-06 Epic Pharma Llc (10% Owner) Sale 122,200 .12 15,152
2013-10-29 Epic Investments, Llc (10% Owner) Sale 466,000 .13 59,182
2013-10-29 Nigalaye Ashok G (Chief Scientific Officer) Sale 139,800 .13 17,754
2013-10-29 Narine Jeenarine (Director) Sale 102,520 .01 1,332
2013-10-29 Epic Pharma Llc (10% Owner) Sale 466,000 .13 59,182
2013-10-28 Epic Investments, Llc (10% Owner) Sale 465,000 .13 60,450
2013-10-28 Nigalaye Ashok G (Chief Scientific Officer) Sale 139,500 .13 18,135
2013-10-28 Narine Jeenarine (Director) Sale 102,300 .13 13,299
2013-10-28 Epic Pharma Llc (10% Owner) Sale 465,000 .13 60,450
2013-01-22 Epic Investments, Llc (10% Owner) Sale 356,700 .09 32,103
2013-01-22 Nigalaye Ashok G (Chief Scientific Officer) Sale 356,700 .09 32,103
2013-01-22 Potti Ram (10% Owner) Sale 356,700 .09 32,103
2013-01-22 Narine Jeenarine (Director) Sale 356,700 .09 32,103
2013-01-22 Epic Pharma Llc (10% Owner) Sale 356,700 .09 32,103
2013-01-14 Epic Investments, Llc (10% Owner) Option Ex 6,032,000 .06 380,016
2013-01-14 Nigalaye Ashok G (Chief Scientific Officer) Option Ex 6,032,000 .06 380,016
2013-01-14 Potti Ram (10% Owner) Option Ex 6,032,000 .06 380,016
2013-01-14 Narine Jeenarine (Director) Option Ex 6,032,000 .06 380,016
2013-01-14 Epic Pharma Llc (10% Owner) Option Ex 6,032,000 .06 380,016
2013-01-11 Epic Investments, Llc (10% Owner) Sale 2,339,000 .09 212,849
2013-01-11 Nigalaye Ashok G (Chief Scientific Officer) Sale 2,339,000 .09 212,849
2013-01-11 Potti Ram (10% Owner) Sale 2,339,000 .09 212,849
2013-01-11 Narine Jeenarine (Director) Sale 2,339,000 .09 212,849
2013-01-11 Epic Pharma Llc (10% Owner) Sale 2,339,000 .09 212,849
2013-01-03 Epic Investments, Llc (10% Owner) Sale 531,185 .15 79,677
2013-01-03 Nigalaye Ashok G (Chief Scientific Officer) Sale 531,185 .15 79,677
2013-01-03 Narine Jeenarine (Director) Sale 531,185 .15 79,677
2013-01-03 Epic Pharma Llc (10% Owner) Sale 531,185 .15 79,677
2012-12-26 Epic Investments, Llc (10% Owner) Sale 561,000 .09 51,051
2012-12-26 Nigalaye Ashok G (Chief Scientific Officer) Sale 561,000 .09 51,051
2012-12-26 Potti Ram (Director) Sale 561,000 .09 51,051
2012-12-26 Narine Jeenarine (Director) Sale 561,000 .09 51,051
2012-12-26 Epic Pharma Llc (10% Owner) Sale 561,000 .09 51,051
2012-12-19 Epic Investments, Llc (10% Owner) Sale 243,300 .09 22,383
2012-12-19 Nigalaye Ashok G (Chief Scientific Officer) Sale 243,300 .09 22,383
2012-12-19 Potti Ram (Director) Sale 243,300 .09 22,383
2012-12-19 Narine Jeenarine (Director) Sale 243,300 .09 22,383
2012-12-19 Epic Pharma Llc (10% Owner) Sale 243,300 .09 22,383
2012-12-10 Ward Carter Julian (Chief Financial Officer, Sec.) Sale 201,192 .08 15,692
2012-04-19 Treppel Jerry (Chairman & CEO) Sale 3,200 .14 454
2012-03-27 Nigalaye Ashok G (Chief Financial Officer) Sale 735,000 .09 66,150
2012-03-27 Potti Ram (Director) Sale 735,000 .09 66,150
2012-03-27 Narine Jeenarine (Director) Sale 735,000 .09 66,150
2012-03-27 Epic Pharma Llc (10% Owner) Sale 1,470,000 .09 132,300
2012-03-26 Nigalaye Ashok G (Chief Financial Officer) Sale 225,000 .10 21,375
2012-03-26 Potti Ram (Director) Sale 225,000 .10 21,375
2012-03-26 Narine Jeenarine (Director) Sale 225,000 .10 21,375
2012-03-26 Epic Pharma Llc (10% Owner) Sale 450,000 .10 42,750
2012-03-23 Ward Carter Julian (Chief Financial Officer, Sec.) Sale 200,000 .09 18,800
2012-03-23 Nigalaye Ashok G (Chief Financial Officer) Sale 1,765,000 .10 169,440
2012-03-23 Potti Ram (Director) Sale 1,765,000 .10 169,440
2012-03-23 Narine Jeenarine (Director) Sale 1,765,000 .10 169,440
2012-03-23 Epic Pharma Llc (10% Owner) Sale 3,530,000 .10 338,880
2012-03-16 Epic Investments, Llc (10% Owner) Sale 85,000 .10 8,585
2012-03-16 Nigalaye Ashok G (Chief Scientific Officer) Sale 85,000 .10 8,585
2012-03-16 Potti Ram (Director) Sale 85,000 .10 8,585
2012-03-16 Narine Jeenarine (Director) Sale 85,000 .10 8,585
2012-03-16 Epic Pharma Llc (10% Owner) Sale 85,000 .10 8,585
2012-01-26 Potti Ram (Director) Sale 407,949 .12 48,953
2011-05-25 Usdan Adam Sale 1,435,000 .13 192,290
2011-05-24 Usdan Adam Sale 300,000 .16 48,900
2011-04-12 Usdan Adam Sale 200,000 .14 27,200
2011-04-11 Usdan Adam Sale 310,794 .09 29,214
2011-04-06 Usdan Adam Sale 187,100 .07 13,658
2011-03-31 Usdan Adam Sale 36,000 .08 3,024
2011-02-24 Usdan Adam Sale 186,314 .06 11,178
2011-02-23 Usdan Adam Sale 141,084 .06 8,465
2011-02-03 Ward Carter Julian (Chief Financial Officer) Buy 426,192 .04 17,047
2011-02-03 Potti Ram (Director) Buy 407,949 .04 16,317
2011-02-03 Narine Jeenarine (Director) Buy 407,949 .04 16,317
2011-02-03 Dick Chris (President & COO) Buy 426,192 .04 17,047
2011-02-03 Dash Barry H (Director) Buy 340,954 .04 13,638
2011-02-03 Treppel Jerry (Chairman & CEO) Buy 587,834 .04 23,513
2011-02-03 Whitnell Jeffrey A (Director) Buy 340,954 .04 13,638
2011-02-02 Nigalaye Ashok G (Chief Scientific Officer) Buy 407,949 .04 16,317
2011-01-11 Usdan Adam Sale 200,000 .06 12,600
2011-01-10 Usdan Adam Sale 310,794 .07 21,444
2010-12-30 Usdan Adam Sale 170,000 .04 7,650
2010-12-17 Usdan Adam Sale 33,000 .04 1,452
2010-12-15 Usdan Adam Sale 17,000 .04 765
2010-12-06 Usdan Adam Sale 3,100 .06 170
2010-11-18 Usdan Adam Sale 60,000 .06 3,840
2010-11-17 Usdan Adam Sale 26,106 .05 1,305
2010-11-16 Usdan Adam Sale 159,178 .05 7,958
2010-10-07 Usdan Adam Sale 2,000 .06 120
2010-10-06 Usdan Adam Sale 24,000 .06 1,440
2010-10-05 Usdan Adam Sale 2,523 .06 151
2010-10-04 Usdan Adam Sale 11,000 .06 660
2010-10-01 Usdan Adam Sale 12,700 .06 762
2010-09-29 Usdan Adam Sale 24,000 .06 1,440
2010-09-28 Usdan Adam Sale 24,000 .06 1,440
2010-09-27 Usdan Adam Sale 188,000 .06 11,092
2010-07-16 Treppel Jerry (Chairman & CEO) Buy 500,000 .07 34,500
2010-05-24 Usdan Adam Sale 75,180 .09 6,841
2010-05-20 Usdan Adam Sale 85,495 .09 7,267
2010-05-13 Usdan Adam Sale 5,000 .09 425
2010-05-07 Usdan Adam Sale 27,405 .09 2,329
2010-05-04 Usdan Adam Sale 500 .09 42
2010-04-30 Usdan Adam Sale 119,219 .08 9,775
2010-04-29 Usdan Adam Sale 76,800 .08 5,990
2010-01-15 Usdan Adam (10% Owner) Sale 25,287 .10 2,655
2010-01-14 Usdan Adam (10% Owner) Sale 1,500 .11 165
2010-01-11 Usdan Adam (10% Owner) Sale 59,900 .11 6,589
2010-01-08 Usdan Adam (10% Owner) Sale 41,100 .11 4,521
2010-01-07 Usdan Adam (10% Owner) Sale 158,250 .11 17,565
2010-01-06 Usdan Adam (10% Owner) Sale 138,192 .11 15,201
2010-01-04 Usdan Adam (10% Owner) Sale 173,271 .11 19,233
2009-12-31 Usdan Adam (10% Owner) Sale 212,500 .11 23,375
2009-12-30 Usdan Adam (10% Owner) Sale 80,750 .11 8,963
2009-12-29 Usdan Adam (10% Owner) Sale 39,250 .11 4,317
2009-12-24 Usdan Adam (10% Owner) Sale 80,000 .11 8,960
2009-12-21 Usdan Adam (10% Owner) Sale 55,000 .10 5,775
2009-12-16 Usdan Adam (10% Owner) Sale 85,000 .11 9,435
2009-12-15 Usdan Adam (10% Owner) Sale 10,000 .11 1,100
2009-12-14 Usdan Adam (10% Owner) Sale 35,000 .11 3,850
2009-12-11 Usdan Adam (10% Owner) Sale 5,000 .11 550
2009-12-08 Usdan Adam (10% Owner) Sale 93,500 .11 10,285
2009-12-07 Usdan Adam (10% Owner) Sale 1,500 .12 180
2009-12-04 Usdan Adam (10% Owner) Sale 45,000 .11 4,950
2009-12-03 Usdan Adam (10% Owner) Sale 45,000 .12 5,625
2009-12-02 Usdan Adam (10% Owner) Sale 678,584 .15 101,787
2009-12-01 Usdan Adam (10% Owner) Sale 36,416 .10 3,641
2009-11-20 Usdan Adam (10% Owner) Sale 49,500 .10 4,950
2009-11-19 Usdan Adam (10% Owner) Sale 80,500 .10 8,050
2009-11-16 Usdan Adam (10% Owner) Sale 230,000 .12 26,680
2009-11-13 Usdan Adam (10% Owner) Sale 10,000 .12 1,200
2009-11-12 Usdan Adam (10% Owner) Sale 90,000 .11 10,260
2009-11-11 Usdan Adam (10% Owner) Sale 90,000 .12 10,710
2009-11-09 Usdan Adam (10% Owner) Sale 225,000 .10 22,500
2009-11-06 Usdan Adam (10% Owner) Sale 39,000 .09 3,666
2009-11-05 Usdan Adam (10% Owner) Sale 25,000 .10 2,375
2009-11-04 Usdan Adam (10% Owner) Sale 38,500 .10 3,657
2009-10-30 Usdan Adam (10% Owner) Sale 107,500 .09 9,675
2009-10-29 Usdan Adam (10% Owner) Sale 100,000 .08 8,300
2009-10-28 Usdan Adam (10% Owner) Sale 180,000 .08 15,120
2009-10-27 Usdan Adam (10% Owner) Sale 235,000 .10 24,205
2009-10-26 Usdan Adam (10% Owner) Sale 500,000 .11 55,500
2009-07-21 Usdan Adam (10% Owner) Sale 138,528 .06 8,727
2009-07-15 Usdan Adam (10% Owner) Sale 561,342 .07 39,293
2009-04-08 Usdan Adam (10% Owner) Sale 393,200 .13 51,116
2009-04-06 Usdan Adam (10% Owner) Sale 174,252 .15 26,137
2009-04-03 Usdan Adam (10% Owner) Sale 220,700 .17 37,519
2008-09-19 Behl Charan (Other) Buy 10,000 .09 900
2008-07-23 Behl Charan (Other) Buy 20,000 .34 6,700
2008-07-21 Behl Charan (Other) Buy 10,000 .36 3,650
2008-07-18 Behl Charan (Other) Buy 10,000 .37 3,700
2008-07-17 Behl Charan (Other) Buy 15,000 .35 5,250
2008-07-15 Behl Charan (Other) Buy 5,000 .34 1,700
2008-07-09 Behl Charan (Other) Buy 15,000 .40 5,940
2008-04-02 Behl Charan (Other) Buy 15,000 .80 12,000
2008-03-28 Behl Charan (Other) Buy 5,000 .90 4,500
2008-03-26 Behl Charan (Other) Buy 5,000 .96 4,795
2008-02-08 Behl Charan (Other) Buy 5,000 1.04 5,225
2008-02-07 Behl Charan (Other) Buy 10,000 .90 9,000
2008-02-05 Behl Charan (Other) Buy 25,000 .77 19,125
2008-01-30 Behl Charan (Other) Buy 15,000 .94 14,100
2008-01-29 Behl Charan (Other) Buy 10,000 1.00 10,000
2008-01-28 Behl Charan (Other) Buy 8,000 1.15 9,200
2008-01-25 Behl Charan (Other) Buy 10,000 1.16 11,600
2007-12-31 Berk Bernard (Chairman, CEO and President) Buy 5,000 2.06 10,320
2007-11-21 Berk Bernard (CEO and Chairman) Buy 12,500 2.03 25,400
2007-11-20 Berk Bernard (CEO and Chairman) Buy 10,000 2.18 21,840
2006-07-03 Dash Barry H (Director) Buy 7,000 2.36 16,541
2005-07-01 Berk Bernard (Chief Exec Officer a) Buy 12,000 3.07 36,816
2005-06-30 Berk Bernard (Chief Exec Officer a) Buy 20,000 3.02 60,500
2005-03-11 Sichel Eric L (Director) Sale 20,000 4.18 83,660

Insider trading activities including stock purchases, stock sales, and option exercises of ELTP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Elite Pharmaceuticals Inc /de/ (symbol ELTP, CIK number 1053369) see the Securities and Exchange Commission (SEC) website.